Emergency gastrointestinal surgery (EGS) conditions represent a significant healthcare burden globally requiring emergency operations that are associated with mortality rates as high as 80%. EGS is currently focused on quality improvement and internal audits, which occurs at a national or local level. An appreciation of what EGS trials are being conducted is important to reduce research wastage and develop coordinated research strategies in surgery. The primary aim of this study was to identify and quantify recent and active trials in EGS. The secondary aim was to identify conditions of interest and which aspects of care were being modified.
E mergency general surgery (EGS) conditions represent a significant healthcare burden globally. 1 Many of these conditions require emergency operations, with associated mortality rates ranging from 1.1% at 24 hours to 8.6% at 30 days. Even in high-income countries such as the UK where high-risk emergency surgical procedures account for 12.5% of total operations, death rates are as high as 80%. 1, 2 In addition, routine procedures in emergency surgery such as small bowel resection are associated with high morbidity rates, which has further implications for patient recovery and healthcare costs. [1] [2] [3] EGS activity is currently focused on quality improvement and audits at a local or national level. These include the National Emergency Laparotomy Audit in the UK and the National Surgical Quality Improvement Partnership in the United States. 2, 4 Quality improvement relies on a high-quality evidence base to guide efforts that are primarily designed to improve patient outcomes. It is recognized that EGS lacks a high-quality evidence base, 5 which may account for why many aspects of surgical practice are based upon dogma. 6 To generate high-quality evidence to improve patient outcomes, it is necessary to conduct randomized clinical trials. The conduct of a clinical trial can take many years as funding and governance approvals must be secured, along with delivery of the study and analysis of findings. This means that there can be a significant period between the registration of a trial and the publication of findings. Knowing which trials are in progress is important to reduce research wastage and develop coordinated research strategies in surgery. It is considered standard practice for clinical trials to be registered on a database. This helps to prevent duplication and may also protect against publication bias.
The primary aim of this study was to identify and quantify recent and active trials in EGS. The secondary aim was to categorize research according to geographic base, funding body, condition of interest, and intervention being trialed to grasp a better idea of what evidence-based research in emergency surgery is currently being undertaken.
Search Strategy
Information on emergency surgery trials was sourced from the UK Clinical Trials, 9 UK Research and Innovation (UKRI), 10 US Clinical Trials, 11 Australian New Zealand Clinical Trials Registry (ANZCTR), 12 World Health Organization International Clinical Trials Registry Platform (ICTRP), 13 and Canadian International Standard Registered Clinical sTudy Number (ISRCTN), 14 databases online. To provide an accurate picture of current clinical trials underway in emergency surgery, search limitations were set to addressing any study registered or actively recruiting between January 2013 and January 2018. Searches were conducted of each database using a selection of terms with broad reference to EGS and specific high-risk diagnoses. 15 These include "Emergency Surgery" OR "Appendicitis" OR "Diverticulitis" OR "Bowel Obstruction" OR "Pancreatitis" OR "Cholecystitis" OR "Peritonitis" OR 'Laparotomy" OR "Acute abdomen" OR "Diverticulitis" without language restrictions.
Inclusion and Exclusion Criteria
EGS trials were defined as randomized controlled trials investigating non-elective and unplanned surgery of the GI tract. These included procedures from the upper esophageal sphincter to anus, abdominal wall disease, and liver disease. Studies addressing vascular, neurological, gynecological, thoracic surgical emergencies, and pharmacological testing were excluded, as were those registered before 2013 or not currently active during the relevant period.
Study Selection
Searches were conducted by one researcher. The title and abstract of each remaining database results were independently assessed by both researchers to confirm eligibility. Where there was a disagreement over eligibility, the abstract was discussed by researchers to reach an agreement.
Data Extraction
Information regarding trial name, start date, sponsor, funding body, and location of study was tabulated on an Excel spreadsheet. Multicenter trials were localized according to their primary clinical unit (the location of the chief investigator). Interventions were assigned into one of five categories "Procedural" (i.e., focusing on a specific procedure or aspect of a procedure during surgery including comparing surgical interventions with medical interventions), "Non-surgical" (i.e., not testing a surgical intervention), "Perioperative" (i.e., those interventions taking place in theater), "Postoperative" (i.e., those interventions taking place after surgery), and "Other" (none of the above). Categories of funding source were defined in line with internationally selected guidelines. 16 As this is a systematic analysis of trials concerned with overview of current activity, no quality or bias assessment was performed.
RESULTS

Search Results
The research identified 5603 trials from initial screening. After removal of duplicates, 4492 unique records were identified (Fig. 1) . These underwent dual screening and 48 records were identified. Those excluded did not meet the inclusion criteria, being identified from broad search terms. After full review of their registration, six were removed for the following reasons: not active or registered within the selected time period (SCARELESS, CReST, and LEONARDO; n = 3); observational study (STELLA; n = 1); preventative or diagnostic procedure (prophylaxis of post-ERCP pancreatitis using temporary pancreatic stent vs. rectal nonsteroidal anti-inflammatory drug and the use of different-sized US-guided needles in the diagnosis of acute appendicitis; n = 2).
In total, 42 trials were identified. Fourteen were identified from ICTRP, 11 from the US clinical trials database, 10 from UK clinical trials, three from the ANZCTR and ISRCTN, respectively, and one from UKRI (see Table, Supplemental Digital Content 1, http://links.lww.com/TA/B231). These addressed emergency surgery (n = 9), cholecystitis (n = 6), pancreatitis (n = 3), laparotomy (n = 5), appendicitis (n = 11), bowel obstruction (n = 2), acute abdomen (n = 1), and diverticulitis (n = 5). A summary list of trials identified is presented in Table 1 .
Timing and Type of Intervention
Over 50% (n = 23) studies were found to be investigating a procedure within the operating theater, for example, using different techniques or different equipment. Nine studies investigated non-surgical management, such as using antibiotics to treat appendicitis followed by a delayed appendicectomy or the use of gastrografin for bowel obstruction. Six studies were focused on addressing perioperative factors, for example, the use of IV fluids during operating to improve outcomes or the insertion of rectus sheath blocks at the end of surgery to improve postoperative pain intensity. Three of the studies were focused on postoperative outcomes mainly looking at physiotherapy and quality improvement in postoperative care. Two studies were classified as "other" focusing on the use of telemedicine in the remote management of damage control surgery and the use of a smartphone in assessing surgical site infections. Graphical representation of intervention categories is highlighted in Figure 2 .
Funding Source
Hospital-based funding was the most common funding category accounting for 30 trials. The category named affiliated medical research bodies was the second most common funding category with eight trials. These included the NIHR (National Institute of Health Research), the UK MRC (Medical Research Council), Canadian Forces Medical Services, Hungarian Pancreatic Study Group, and Southwest Oncology Group. Private sponsors (n = 3) are individually named sponsors. Commercially based sponsors included Bupa, a private health insurance company.
Emergency Surgery
Nine studies addressed emergency surgery in general. Three of these trials focused on EGS procedures, such as laparoscopic versus open surgery (LaCeS), using nanotechnologies as a fixing method for prosthetic materials in emergency laparoscopic procedures, and the role of endoluminal stenting in the acute management of obstructing colorectal cancer. Two trials were categorized as perioperative management, investigating fluid optimization in emergency laparotomy (FLO-ELA) and comparing direct and guidewire-assisted techniques to artery cannulation in patients posted for emergency surgery and the association between oxygen saturations and postoperative cognitive dysfunction in the elderly undergoing EGS. The single postoperative trial investigated the outcomes of enhanced rehabilitation in patients after EGS. One trial was categorized as "other" investigating whether the use of a smartphone tool aided the earlier identification and management of surgical site infections in EGS patients. Four of the studies were carried out in the UK, one in China, France, India, Italy, and Tasmania, respectively. Five studies received hospital funding; three were funded by affiliated medical research bodies. The remaining study was privately funded.
Laparotomy
Five studies investigating laparotomy were identified. Two studies were categorized as procedural, investigating the outcomes of damage control surgery and comparing endoscopically assisted colostomy with colopexy to laparotomy (EACC). Two other trials were categorized as "perioperative"; one was based in the UK looking at interventions for quality improvement for patients undergoing emergency laparotomy (EPOCH) and the other was based in Dubai investigating the post-surgical use of rectal sheath blocks for pain management. One trial addressing laparotomy was categorized as "other", investigating the use of telemedicine to mentor surgeons in damage control surgery for critically injured trauma patients from afar. This trial took place in Canada and was funded by the Canadian Armed Forces. One trial (EPOCH) was funded by the NIHR, two trials received hospital-based funding, and one trial was privately funded in Dubai.
Appendicitis
Eleven trials addressing acute appendicitis were identified. Six trials were categorized as "non-surgical" and investigated the outcomes of antibiotics for the treatment of appendicitis when compared with surgery. Notably, four of these trials (CONTRACT, APPY, COMMA, and CHINA) were focused exclusively on pediatric populations. Four trials investigated procedural techniques for appendicectomy. This included the use of polymer clips versus endoloops (PECAS), clips versus staples, the use of single versus multiple ports, and an interval appendicectomy post-antibiotic therapy for acute appendicitis (CHINA). Four (36%) of the trials originated from the United States, three in the UK, one in Taiwan, and the remaining three in Europe (see 
Cholecystitis
Six EGS trials addressed cholecystitis, five (83%) of which focused on EGS procedures, including intra-operative ERCP versus laparoscopic bile duct exploration for bile duct clearance in patients undergoing emergency cholecystitis, immediate versus delayed laparoscopic cholecystectomy in two trials, laparoscopic versus conservative treatment in acute cholecystitis, and intragallbladder or systemic Indocyanine green injection to facilitate cholecystectomy in patients with acute cholecystitis. One study investigated the use of extended antibiotic therapy postoperatively in reducing infections. Five (83%) of the studies were hospital funded, and one was privately funded. All six of the trials were carried out in different countries including Australia, Argentina, Finland, Japan, Taiwan, and Saudi Arabia.
Bowel Obstruction
Two studies addressing bowel obstruction were identified. The first study investigated the non-surgical use of water-soluble 
Diverticulitis
Five studies addressing diverticulitis were identified. Four (80%) of the studies were procedure-based EGS trials comparing laparoscopic lavage versus primary resection of an area of the colon in the treatment of acute diverticulitis. The remaining trial addressing diverticulitis was categorized as non-surgical investigating the rate of surgical site infection using vacuum-assisted therapy in emergent contaminated abdominal surgery. One of the trials was being undertaken in the United States, the remaining three within Europe. All five (100%) of the trials were funded by hospital-based funding.
Acute Pancreatitis
Three studies addressed pancreatitis. All three were categorized as "procedural", one study investigated the use of stents for acute necrotizing pancreatitis, one compared the use of a stent versus no stent in acute pancreatitis, and the other investigated the optimal time for cholecystectomy in acute biliary pancreatitis. One study was carried out in a US hospital where the funding originated. The second study took place in Hungary and was funded by the Hungarian pancreatic study group. The third study was undertaken in Egypt and was funded by the local hospital.
Acute Abdomen
One study addressing acute abdomen was identified (CLIPPER2). This trial compared the related morbidity rates of two different procedures: surgical versus endoscopic closure in patients with acute colonic perforations. The study took place in Germany and received local hospital-based funding.
DISCUSSION
This study identified 42 EGS trials with activity in the last 5 years. We found that the majority of recent trials within emergency surgery are addressing low mortality conditions such as appendicitis (n = 11), not those with high mortality rates such as emergency laparotomy (n = 5). 17 Although initial searches gathered nearly 4000 studies, on reviewal by the research team, the majority of studies were not research in emergency surgery, merely being identified within the database because of the search term used. Across all settings, funding was typically secured at a local level (n = 30), and 11 trials (26%) had cohorts less than 100 participants. Studies with smaller sample sizes, either caused by a lack of funding or challenges in recruitment, may hinder the progression of the EGS evidence base and perhaps only offering marginal gains. 18 In general, surgical trials are aimed at either improving long-term outcomes or perioperative morbidity in the elective setting, despite there being a lower risk of morbidity and mortality than seen in the EGS population. When comparing the population affected by emergency surgical conditions, and the evidence base to support interventions to the number affected and volume-based research within elective surgery, there is a large disparity. Our evidence is supported by Morley et al., 19 which identified between 2010 and 2012 that only 39 out of 414 trials addressing surgery were aimed at emergency surgery. Their study showed that both emergency and elective study trials had equal risks of being terminated early and were equally likely to be published once registered. This implies that EGS research has equal opportunities for success as that in elective settings, and more must to be done to bridge the gap in research. This study did not undertake formal comparison of the number of EGS trials to another clinical area as the research team could not select a suitable comparator population or condition.
Searches within each database showed that several EGSrelated studies were registered in the study period. Many did not meet the inclusion criteria because there were either observational studies or case series with very few participants. 20 Observational studies have an important role in informing surgical practice including describing epidemiology, outcomes, and identifying potential areas for intervention. However, observational studies are poorly suited to attributing causation and testing solutions without considerable risk of selection bias. Trials in the emergency setting are challenging to conduct as emergency care is often delivered when time and resources are pressured. 21 There are potential challenges in identifying and recruiting patients, alongside implementing interventions in a timely and standardized manner. These practical issues require further research. Nevertheless, conducting surgical trials in this setting is possible, as is done routinely in intensive care medicine and in emergency medicine. 22 There are numerous challenges in the delivery of EGS trials. First, the population of high-risk emergency surgical patients is highly heterogeneous. These patients often have complex multisystem disease and uncertain diagnoses that may only be identified intraoperatively or even postoperatively. This represents a challenge in the recruitment and delivery of interventions. Second, this patient group is often critically unwell, and clinical delay caused by research may present barriers to recruitment. In addition, there is variation in practice and scope of EGS and constituent teams globally, which could contribute to the difficulty in enrolling patients in areas less well supported. There are, however, some factors that should improve the feasibility of EGS trials. Emergency general surgery conditions are also common, meaning that a large population is available to participate in trial. Morbidity and mortality in this group are common, and often occur close to the index event of surgery, 23 potentially meaning shorter-term followups are necessary to assess outcomes.
Our study identified very few EGS trials outside of highincome settings with clinically significant sample sizes. Populations in low-income and middle-income settings have a higher requirement for emergency surgical services and poorer outcomes than high-income populations. 24 However, in our study, the studies we identified within low-income to middle-income countries had very few participants. Four out of the nine studies identified with fewer than 100 participants were carried out in low-income to middle-income countries (EACC, single-incision laparoscopic surgery in acute abdomen, acute biliary pancreatitisoptimal time for cholecystectomy, and the onset time of rocuronium in emergency and elective surgery). These settings present unique challenges and may be where the greatest gains in outcome may be. Identifying interventions that are effective in improving outcomes from emergency surgery across the world would enable a far larger population to benefit. There are multiple reasons why surgical trials may not have been identified in these settings. First, these countries may not have requirements to register clinical trials prospectively and hence would not have been identified by our searches. This is unlikely as we searched multiple international databases and the requirement for prospective registration is common. Secondly, resource and ethical limitations may play a role. Clinicians in these settings are more stretched, dedicating most of their time to service provision and leaving very limited time for participant recruitment or data collection. Moreover, they may lack the necessary resources to undertake research. International initiatives are aiming to change this, with capacity-building networks being formed in surgery, such as the GlobalSurg collaborative, 25 who have just launched a factorial randomized trial investigating skin preparation.
This study is not without limitations. Although it is expected that all trials are registered after the legislation implemented by the International Committee of Medical Journal Editors in 2005, 26 it is possible that some may not be identified through the searches. We did not search for resulting publications and were unable to account for unpublished research, nor research that remains within the hospital or country where it was carried out, meaning it is available globally. This could be resolved by streamlining the regulation process, making all studies from the various databases available on one global database with unlimited international access. This would also make it simpler for authors to both recruit and register trials globally. However, a recent study suggests that 46% of EGS trials are published. 19 We recognize that the findings of our study may age if significant changes are made to encourage future emergency surgery research; however, it will provide a useful benchmark progress in this field. The strengths of this study include adherence to methodological principles, dual review of candidate studies, and interrogation of multiple databases using multiple search terms, meaning the majority of candidate studies should have been identified. This allows a robust estimate of international trial activity in EGS.
For elective surgery, time for preoperative optimization and careful planning provide a controlled environment to undertake research aimed at improving surgical and perioperative outcomes. This is not a luxury afforded to research in the emergency setting. Nevertheless, this study highlights that there is a large disparity in the number of randomized trials in elective versus emergency surgery that are currently being performed. It is imperative that this gap is addressed to improve both the quantity and quality of the literature in this field, which is key for improving EGS outcomes. Future studies should focus on high-risk groups (i.e., emergency laparotomy), in addition to high-volume groups (i.e., appendicitis) for maximal benefit. Researcher teams should include the wider surgical team, anesthetists, intensivists, emergency physicians, and methodologists. Teams should work to optimize trial designs to answer important research questions robustly, while adequately addressing the complex challenges to research in the emergency setting. 27 One way to improve outcomes in emergency surgeries is by making funding more accessible. It was notable in this review that many of the studies were supported by local hospital funds, rather than national-level funders such as the NIHR in the UK or the National Institute for Health in the use. These strategic funding bodies could consider commissioned calls for EGS projects and incentivization of units to deliver emergency surgery research. This may help to increase the number of trials that are addressing high-morbidity conditions such as laparotomy and bowel obstruction.
There is large disparity in the number of surgical trials in emergency surgery, which are primarily focused on high-volume conditions. More research is needed into high-mortality conditions. Future efforts should focus on improving both the quantity and quality of research in these patients and ensuring findings are generalizable for patients across the world.
